Signed in as:
filler@godaddy.com
NanoTess is using revolutionary technology to solve some the world's toughest health challenges beginning with chronic wounds
NanoTess is using revolutionary technology to solve some the world's toughest health challenges beginning with chronic wounds
people in North America are suffering with diabetic foot ulcers
of diabetic foot ulcers will lead to a lower-limb amputation
relative 5-year mortality rate after a lower-limb amputation
Learn more about NanoTess' patented, Health Canada approved nanotechnology for the management of chronic wounds and topical challenges.
NanoTess is a values-based enterprise with a vision to "prevent unnecessary suffering through technological innovation." Our team has over 40 years of cumulative experience in material science developing innovative solutions to solve a wide variety of health-related needs. Our initial focus is on helping patients with chronic wounds like diabetic foot ulcers. Apart from our strong focus on our bottom line, NanoTess aims to ensure our products are accessible and affordable for those who need them. By focusing on patient-first solutions, we believe we can create cutting edge technologies that bring value to all stakeholders. NanoSALV is approved by Health Canada under license no. 108235 and no. 108236. NanoTess is certified as per ISO 13485:2016 / MDSAP.
Invisible to the naked eye and 1000 times smaller than bacteria, nanotechnology solutions provide several exciting opportunities. Nanomedicine forms the basis for the next revolution within the health industry. NanoTess' approach is unique and focuses on the use of small and mighty solutions to address unmet health needs. Our journey starts with chronic wounds.
Steering catalytic reactions for optimized therapeutic outcomes.
From cosmetics to antimicrobials and even cancer therapies, nanotechnology leverages nature's building blocks to create targeted solutions.
A possible next generation field that is able to advance wound healing to cure chronic wounds.
